Macrophages in periapical lesions

Dental Traumatology

Volumn 16, Issue 1, 2000, Pages 1-8

  Metzger, Z ^a,b  

^a TEL AVIV UNIVERSITY   (Israel)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CYTOKINE; ENDOTOXIN;

ANTIBODY PRODUCTION; HUMAN; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MACROPHAGE; MACROPHAGE ACTIVATION; OSTEOCLAST; OSTEOLYSIS; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; T LYMPHOCYTE; TOOTH PERIAPICAL DISEASE;

ANTIBODY FORMATION; ANTIGENS; BONE RESORPTION; CYTOKINES; ENDOTOXINS; HUMANS; LYMPHOCYTE ACTIVATION; MACROPHAGE ACTIVATION; MACROPHAGES; OSTEOCLASTS; PERIAPICAL DISEASES; PERIAPICAL GRANULOMA; T-LYMPHOCYTES;

EID: 85046527829     PISSN: 16004469     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-9657.2000.016001001.x     Document Type: Review

References (50)

1. Stern MH, Dreizen S, Mackler BF, Selbst AG, Levy BM. Quantitative analysis of cellular composition of human periapical granuloma. J Endod 1981;7:117-22.
2. Stern MH, Dreizen S, Mackler BF, Levy BM. Isolation and characterization of inflammatory cells from the human periapical granuloma. J Dent Res 1982;61:1408-12.
3. Kopp W, Schwarting R. Differentiation of T lymphocyte subpopulations, macrophages, and HLA-DR-restricted cells of apical granulation tissue. J Endod 1989;15:72-5.
4. Piattelli A, Artese L, Rosini S, Quaranta M, Musiani P. Immune cells in periapical granuloma: morphological and immunohistochemical characterization. J Endod 1991;17:26-9.
5. Kawashima N, Okiji T, Kosaka T, Suda H. Kinetics of macrophages and lymphoid cells during the development of experimentally induced periapical lesions in rat molars: a quantitative immunohistochemical study. J Endod 1996;22:311-6.
6. Akamine A, Hashiguchi I, Toriya Y, Maeda K. Immunohistochemical examination on the localization of macrophages and plasma cells in induced rat periapical lesions. Endod Dent Traumatol 1994;10:121-8.
7. Ofek I, Goldhar J, Keisari Y, Sharon N. Nonopsonic phagocytosis of microorganisms. Annu Rev Microbiol 1995;49:239-76.
8. Okiji T, Kawashima N, Kosaka T, Kobayashi C, Suda H. Distribution of Ia antigen-expressing nonlymphoid cells in various stages of induced periapical lesions in rat molars. J Endod 1994;20:27-31.
9. Artese L, Piattelli A, Quaranta M, Colasante A, Musani P. Immunoreactivity for interleukin 1-beta and tumor necrosis factor-alpha and ultrastructural features of monocytes/macrophages in periapical granulomas. J Endod 1991;17:483-7.
10. Johannessen AC, Nilsen R, Skaug N. Deposits of immunoglobulins and complement factor C3 in human dental periapical inflammatory lesions. Scand J Dent Res 1983;91:191-9.
11. Cymerman JJ, Cymerman DH, Walters J, Nevins AJ. Human T lymphocyte subpopulations in chronic periapical lesions. J Endod 1984;10:9-11.
12. Babal P, Soler P, Brozman M, Jakubovsky J, Beyly M, Basset F. In situ characterization of cells in periapical granuloma by monoclonal antibodies. Oral Surg Oral Med Oral Pathol 1987;64:348-52.
13. Barkhordar RA, Desouza YG. Human T-lymphocyte subpopulations in periapical lesions. Oral Surg Oral Med Oral Pathol 1988;65:763-6.
14. Poulter LW, Seymour GJ, Duke O, Janossy G, Panayi G. Immunohistological analysis of delayed-type hypersensitivity in man. Cell Immunol 1982;74:358-69.
15. Stashenko P, Yu SM. T helper and T suppressor cell reversal during the development of induced rat periapical lesions. J Dent Res 1989;68:830-4.
16. Baumgartner JC, Falkler WAJ. Reactivity of IgG from explant cultures of periapical lesions with implicated microorganisms. J Endod 1991;17:207-12.
17. Kettering JD, Torabinejad M, Jones SL. Specificity of antibodies present in human periapical lesions. J Endod 1991;17: 213-6.
18. Wallstrom JB, Torabinejad M, Kettering J, McMillan P. Role of T cells in the pathogenesis of periapical lesions. A preliminary report. Oral Surg Oral Med Oral Pathol 1993;76:213-8.
19. Stashenko P, Dewhirst FE, Rooney ML, Desjardins LA, Heeley JD. Interleukin-1 beta is a potent inhibitor of bone formation in vitro. J Bone Miner Res 1987;2:559-65.
20. Stashenko P. Role of immune cytokines in the pathogenesis of periapical lesions. Endod Dent Traumatol 1990;6:89-96.
21. Klein DC, Raisz LG. Prostaglandins: stimulation of bone resorption in tissue culture. Endocrinology 1970;86:1436-40.
22. Hausmann E, Raisz LG, Miller WA. Endotoxin: stimulation of bone resorption in tissue culture. Science 1970;168:862-4.
23. Stashenko P, Teles R, D'Souza R. Periapical inflammatory responses and their modulation. Crit Rev Oral Biol Med 1998; 9:498-521.
24. Stashenko P, Dewhirst FE, Peros WJ, Kent RL, Ago JM. Synergistic interactions between interleukin 1, tumor necrosis factor, and lymphotoxin in bone resorption. J Immunol 1987;138: 1464-8.
25. Wang CY, Stashenko P. Characterization of bone-resorbing activity in human periapical lesions. J Endod 1993;19:107-11.
26. Wang CY, Stashenko P. The role of interleukin-1 alpha in the pathogenesis of periapical bone destruction in a rat model system. Oral Microbiol Immunol 1993;8:50-6.
27. Kakehashi S, Stanley HR, Fitzgerald RJ. The effect of surgical exposures of dental pulps in germ-free and conventional laboratory rats: Oral Surg Oral Med Oral Pathol 1965;20:340-9.
28. Tani-Ishii N, Kuchiba K, Osada T, Watanabe Y, Umemoto T. Effect of T-cell deficiency on the formation of periapical lesions in mice: histological comparison between periapical lesion formation in BALB/c and BALB/c nu/nu mice. J Endod 1995; 21:195-9.
29. Wang CY, Stashenko P. Kinetics of bone-resorbing activity in developing periapical lesions. J Dent Res 1991;70:1362-6.
30. Hamachi T, Anan H, Akamine A, Fujise O, Maeda K. Detection of interleukin-1 beta mRNA in rat periapical lesions. J Endod 1995;21:118-21.
31. Lim GC, Torabinejad M, Kettering J, Linkhardt TA, Finkelman RD. Interleukin 1-beta in symptomatic and asymptomatic human periradicular lesions. J Endod. 1994;20:225-7.
32. Matsuo T, Ebisu S, Nakanishi T, Yonemura K, Harada Y, Okada H. Interleukin-1 alpha and interleukin-1 beta periapical exudates of infected root canals: correlations with the clinical findings of the involved teeth. J Endod 1994;20:432-5.
33. Dinarello CA. Interleukin-1. Ann N Y Acad Sci 1988;546: 122-32.
34. Pennica D, Nedwin GE, Hayflick JS, Seeburg PH, Derynck R, Palladino MA, et al. Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin. Nature 1984;312:724-9.
35. Metzger Z, Berg D, Dotan M. Fibroblast growth in vitro suppressed by LPS-activated macrophages. Reversal of suppression by hydrocortisone. J Endod 1997;23:517-21.
36. Vos JG, Kreeftenberg JG, Kruijt BC, Kruizinga W, Steerenberg P. The athymic nude rat. II. Immunological characteristics. Clin Immunol Immunopathol 1980;15:229-37.
37. Pritchard H, Riddaway J, Micklem HS. Immune responses in congenitally thymus-less mice. II. Quantitative studies of serum immunoglobulins, the antibody response to sheep erythrocytes, and the effect of thymus allografting. Clin Exp Immunol 1973;13:125-38.
38. Politis AD, Sivo J, Driggers PH, Ozato K, Vogel SN. Modulation of interferon consensus sequence binding protein mRNA in murine peritoneal macrophages. Induction by IFN-gamma and down-regulation by IFN-alpha, dexamethasone, and protein kinase inhibitors. J Immunol 1992;148:801-7.
39. Metzger Z, Hoffeld JT, Oppenheim JJ. Macrophage-mediated suppression. I. Evidence for participation of both hydrogen peroxide and prostaglandins in suppression of murine lymphocyte proliferation. J Immunol 1980;124:983-8.
40. Metzger Z, Hoffeld JT, Oppenheim JJ. Suppression of fibroblast proliferation by activated macrophages: involvement of H2O2 and a non-prostaglandin E product of the cyclooxygenase pathway. Cell Immunol 1986;100:501-14.
41. Tani-Ishii N, Wang CY, Tanner A, Stashenko P. Changes in root canal microbiota during the development of rat periapical lesions. Oral Microbiol Immunol 1994;9:129-35.
42. Tani-Ishii N, Wang CY, Stashenko P. Immunolocalization of bone-resorptive cytokines in rat pulp and periapical lesions following surgical pulp exposure. Oral Microbiol Immunol 1995;10:213-9.
43. Kuo ML, Lamster IB, Hasselgren G. Host mediators in endodontic exudates. I. Indicators of inflammation and humoral immunity. J Endod 1998;24:598-603.
44. Williams RC, Jeffcoat MK, Howell TH, Rolla A, Stubbs D, Teoh KW, et al. Altering the progression of human alveolar bone loss with the non-steroidal anti-inflammatory drug flurbiprofen. J Periodontol 1989;60:485-90.
45. Torbinejad M, Clagett J, Engel D. A cat model for the evaluation of mechanisms of bone resorption: induction of bone loss by simulated immune complexes and inhibition by indomethacin. Calcif Tissue Int 1979;29:207-14.
46. Shapira L, Soskolne WA, Houri Y, Barak V, Halabi A, Stabholtz A. Protection against endotoxic shock and lipopolysaccharide induced local inflammation by tetracycline: correlation with inhibition of cytokine secretion. Infect Immun 1996;64: 825-8.
47. Schultz RM, Chirigos MA, Stoychkov JN, Pavilidis RJ. Factors affecting macrophage cytotoxic activity with particular emphasis on corticosteroidsand acute stress. J Reticuloendothelial Soc 1979;26:83-91.
48. Nakamura Y, Murai T, Ogawa Y. Effect of in vitro and in vivo administration of dexamethasone on rat macrophage functions: comparison between alveolar and peritoneal macrophages. Eur Respir J 1996;9:301-6.
49. Knudsen PJ, Dinarello CA, Strom TB. Glucocorticoids inhibit transcriptional and post-transcriptional expression of interleukin 1 in U937 cells. J Immunol 1987;139:4129-34.
50. Waage A, Slupphaug G, Shalaby R. Glucocorticoids inhibit the production of IL6 from monocytes, endothelial cells and fibroblasts. Eur J Immunol 1990;20:2439-43.